Our Molecular Oncology Board

Expertise guiding clinicians and patients to targeted treatments.

Omico’s Molecular Oncology Board (MOB) is a national, multidisciplinary group that provides expert guidance for precision oncology.

Comprising of specialists from across Australia, the MOB reviews complex comprehensive genomic profiling (CGP) results for participants in Omico’s Cancer Screening Program (CaSP) and provides evidence-based clinical trial and treatment recommendations to guide treating clinicians on potential precision therapy options.

Professor David Thomas

Chair, Medical Oncologist

 

 

Dr Damien Kee

Deputy Chair, Medical Oncologist

 

 

Dr Sam Harris

Medical Oncologist

 

 

Dr Subo Thavaneswaran

Medical Oncologist

 

 

Dr Lia Papadopoulos

Medical Oncologist

 

 

Dr Greg Gaughran

Medical Oncologist

 

 

Dr John Grady

Bioinformatician

 

 

A/Prof Mandy Ballinger

Cancer Genetics

 

 

Dr Milita Zaheed

Cancer Genetics

 

 

Dr Alexandra Jolley

Molecular Pathologist

 

 

 

A/Prof David Moffat

Molecular Pathologist

 

 

Dr Elizabeth (Libby) Blackley

Medical Oncologist

 

 

Dr Siobhan O'Neill

Medical Oncologist

 

 

Dr Richard (Yat Hang) To

Medical Oncologist